Century Therapeutics, Inc.
- IPSC
- NASDAQ
- Biotechnology
- Allogeneic Cell Therapy
- iPSC-Derived CAR-T
- Cancer Immunotherapy
$1.37
Today −8.67%Quote Oct 16, 2026, 08:00 PM UTC
−27.13%over the last month
Max drawdown −32.3%From 1-month high −27.5%3 months −37.4%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$248.1M
Quote Oct 16
Next earnings
Nov 12
Expected, not confirmed
Analyst target
$7.50
+447.4% from here
Floor
$1.26
7.8% below price
Where the price sits
9 analysts
Analyst range, low to high
$2.00$19.00
- Price $1.37
- Resistance $1.43
- Consensus $7.50
Analysts' average target sits about 447% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about IPSCPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
78